G6PC1 and neoplasm: We recently reported that oncomiR-494 can rewire the tumor metabolism of HCC cells by targeting the catalytic subunit of G6pc (Glucose-6 phosphatase), which is a multi-subunit complex catalyzing the dephosphorylation of G6P to free glucose, playing a central role in glucose homeostasis.